MedPath

Mapping Auricular Vagus Nerve Circuitry

Early Phase 1
Recruiting
Conditions
Healthy
Interventions
Device: active TEAS
Registration Number
NCT00200889
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This study will determine how noninvasive nerve stimulation affects human brain, stomach, and autonomic activity.

Detailed Description

Scientific research into the basic mechanisms underlying neuromodulation is relatively recent and incomplete. The purpose of the proposed study is to determine how a form of neuromodulation, transcutaneous electro-accupoint stimulation, which is non-invasive and non-painful, affects human brain, stomach, and autonomic activity. We will accomplish this by integrating whole brain functional MRI (fMRI) methodologies with gastric MRI and physiological monitoring.

This study will comprise 3 functional magnetic resonance imaging (fMRI) brain-gut scans, all while receiving the neuromodulation with varying parameters. Participants will also have their heart rate, breathing, and gastric activity monitored during all visits.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Adults 18-65
  • Functional dyspepsia
Exclusion Criteria
  • Any condition contraindicating an fMRI brain scan

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Congruentactive TEASParticipants receive briefings on expectations of stimulation effects on gastric motility consistent with the literature.
Incongruentactive TEASParticipants receive briefings on expectations of stimulation effects on gastric motility inconsistent with the literature.
Primary Outcome Measures
NameTimeMethod
Stomach activity during gastric magnetic resonance imaging (MRI)30 minutes

Gastric accommodation and sensitivity change between active and inactive auricular tVNS

Brain activity during functional magnetic resonance imaging (fMRI)1 hour

Blood oxygen-level dependent (BOLD) signal change between active and inactive auricular tVNS

Secondary Outcome Measures
NameTimeMethod
Electrogastrography (EGG)2 hours

We will use EGG to measure slow wave myoelectrical activity, as measured by EGG power/peak frequency.

Electrocardiography (ECG)2 hours

We will use ECG to examine high frequency heart rate variability (HF-HRV), i.e. the R-peak of the QRS complex.

Respiration2 hours

Respiration will be measured in beats per minute (bpm).

Skin Conductance Levels (SCL)2 hours

SCL will be measured in volts per second.

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath